Reported 6 months ago
The article discusses two beaten-down dividend stocks, CVS Health and Gilead Sciences, that could be good long-term investments despite recent struggles. CVS Health has seen disappointing financial results due to various factors, including lower revenue from COVID-19 vaccines, but its diversified healthcare services and dividend growth potential make it attractive for income investors. Similarly, Gilead Sciences has faced regulatory challenges but has maintained steady revenue and earnings, particularly from its HIV medicines. Both companies offer attractive dividend yields and growth prospects, making them potentially solid picks for investors willing to hold for 10 years.
Source: YAHOO